# Good Pharmacovigilance Practices and Pharmacoepidemiologic Assessment:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/good-pharmacovigilance-practices-and-pharmacoepidemiologic-assessment-guidance-for-industry/9fb2afd0-d696-4043-9e1d-40673dcaf63a

> FDA guidance document: Good Pharmacovigilance Practices and Pharmacoepidemiologic Assessment:  Guidance for Industry. Issue date: March 24, 2005. Get complete insights and analysis.

---

## Details

- Title: Good Pharmacovigilance Practices and Pharmacoepidemiologic Assessment:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2005-03-24
- Last Changed: 2020-04-22
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2004-D-0041">FDA-2004-D-0041</a>

## Related Documents

- [Premarketing Risk Assessment:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/premarketing-risk-assessment-guidance-for-industry/232a7962-0cba-49be-a6b4-356c35b5f91f)
- [Guidance for Review Staff and Industry Good Review Management Principles and Practices for PDUFA Products](https://www.globalkeysolutions.net/guidances/guidance-document/guidance-for-review-staff-and-industry-good-review-management-principles-and-practices-for-pdufa-products/2063ec1b-8811-4dd6-88f7-f0849ff947a9)
- [Development and Use of Risk Minimization Action Plans:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/development-and-use-of-risk-minimization-action-plans-guidance-for-industry/0c2f3726-2538-48fb-815a-44b28e56a090)